PPARA and obesity disorder: Overall, fenofibrate treatment affects body weight, adipose tissue mass, lipid metabolism, and hepatic β-oxidation with sexual dimorphism, but fenofibrate-regulated obesity is not directly associated with PPARα-mediated action and may be influenced by sex-related factors.